UGT2B17 Genotype and the Pharmacokinetic Serum Profile of Testosterone during Substitution Therapy with Testosterone Undecanoate. A Retrospective Experience from 207 Men with Hypogonadism.
about
Androgen actions on endothelium functions and cardiovascular diseasesEditorial: Variation in Phase II Metabolism of Sex Steroids - Causes and Consequences.Relationship between testosterone in serum, saliva and urine during treatment with intramuscular testosterone undecanoate in gender dysphoria and male hypogonadism.Delivering enhanced testosterone replacement therapy through nanochannels.
P2860
UGT2B17 Genotype and the Pharmacokinetic Serum Profile of Testosterone during Substitution Therapy with Testosterone Undecanoate. A Retrospective Experience from 207 Men with Hypogonadism.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
UGT2B17 Genotype and the Pharm ...... rom 207 Men with Hypogonadism.
@en
UGT2B17 Genotype and the Pharm ...... rom 207 Men with Hypogonadism.
@nl
type
label
UGT2B17 Genotype and the Pharm ...... rom 207 Men with Hypogonadism.
@en
UGT2B17 Genotype and the Pharm ...... rom 207 Men with Hypogonadism.
@nl
prefLabel
UGT2B17 Genotype and the Pharm ...... rom 207 Men with Hypogonadism.
@en
UGT2B17 Genotype and the Pharm ...... rom 207 Men with Hypogonadism.
@nl
P2860
P50
P356
P1476
UGT2B17 Genotype and the Pharm ...... rom 207 Men with Hypogonadism.
@en
P2860
P356
10.3389/FENDO.2013.00094
P577
2013-07-29T00:00:00Z